» Articles » PMID: 29390149

Cord Blood Antiparasite Interleukin 10 As a Risk Marker for Compromised Vaccine Immunogenicity in Early Childhood

Overview
Journal J Infect Dis
Date 2018 Feb 2
PMID 29390149
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Antenatal exposure to parasites can affect infants' subsequent responses to vaccination. The present study investigated how maternal prenatal infections and newborns' antiparasite cytokine profiles relate to immunoglobulin G (IgG) responses to standard vaccination during infancy.

Methods: A total of 450 Kenyan women were tested for parasitic infections during pregnancy. Their newborns' responses to Plasmodium falciparum, schistosome, and filaria antigens were assessed in cord blood lymphocytes. Following standard neonatal vaccination, this infant cohort was followed biannually to age 30 months for measurement of circulating IgG levels against Haemophilus influenzae b (Hib), diphtheria toxoid (DT), hepatitis B virus (HBV), and tetanus toxoid.

Results: Trajectories of postvaccination IgG levels were classified by functional principal component (PC) analysis to assess each child's response profile. Two main components, PC1, reflecting height of response over time, and PC2, reflecting crossover from high to low responses or from low to high responses, were identified. Cord blood cytokine responses to schistosome and filarial antigens showed a significant association between augmented antihelminth interleukin 10 and reduced antibody levels, particularly to DT and HBV, and a more rapid postvaccination decline in circulating IgG levels against Hib.

Conclusion: Antenatal sensitization to schistosomiasis or filariasis and related production of antiparasite interleukin 10 at birth are associated with reduced antivaccine IgG levels in infancy, with possibly impaired protection.

Citing Articles

How does geographical diversity shape vaccine efficacy?.

Abavisani M, Ansari B, Ebadpour N, Sahebkar A Clin Exp Vaccine Res. 2024; 13(4):271-300.

PMID: 39525670 PMC: 11543789. DOI: 10.7774/cevr.2024.13.4.271.


Maternal Helminth Infection Causes Dysfunctional B Cell Development in Male Offspring.

Gibbs L, Oviedo J, Ondigo B, Fairfax K J Immunol. 2024; 213(8):1157-1169.

PMID: 39185897 PMC: 11537230. DOI: 10.4049/jimmunol.2400158.


A New Role for Old Friends: Effects of Helminth Infections on Vaccine Efficacy.

Zhu F, Liu W, Liu T, Shi L, Zheng W, Guan F Pathogens. 2022; 11(10).

PMID: 36297220 PMC: 9608950. DOI: 10.3390/pathogens11101163.


The Road to Elimination: Current State of Schistosomiasis Research and Progress Towards the End Game.

Ogongo P, Nyakundi R, Chege G, Ochola L Front Immunol. 2022; 13:846108.

PMID: 35592327 PMC: 9112563. DOI: 10.3389/fimmu.2022.846108.


Altered Offspring Immunity in Maternal Parasitic Infections.

Gibbs L, Fairfax K J Immunol. 2022; 208(2):221-226.

PMID: 35017211 PMC: 8769501. DOI: 10.4049/jimmunol.2100708.


References
1.
Ibitokou S, Bostrom S, Brutus L, Ndam N, Vianou B, Agbowai C . Submicroscopic infections with Plasmodium falciparum during pregnancy and their association with circulating cytokine, chemokine, and cellular profiles. Clin Vaccine Immunol. 2014; 21(6):859-66. PMC: 4054237. DOI: 10.1128/CVI.00009-14. View

2.
Elias D, Akuffo H, Thors C, Pawlowski A, Britton S . Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice. Clin Exp Immunol. 2005; 139(3):398-404. PMC: 1809318. DOI: 10.1111/j.1365-2249.2004.02719.x. View

3.
King C, Malhotra I, Wamachi A, Kioko J, Mungai P, Wahab S . Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus. J Immunol. 2001; 168(1):356-64. DOI: 10.4049/jimmunol.168.1.356. View

4.
LaBeaud A, Malhotra I, King M, King C, King C . Do antenatal parasite infections devalue childhood vaccination?. PLoS Negl Trop Dis. 2009; 3(5):e442. PMC: 2682196. DOI: 10.1371/journal.pntd.0000442. View

5.
Malhotra I, Wamachi A, Mungai P, Mzungu E, Koech D, Muchiri E . Fine specificity of neonatal lymphocytes to an abundant malaria blood-stage antigen: epitope mapping of Plasmodium falciparum MSP1(33). J Immunol. 2008; 180(5):3383-90. DOI: 10.4049/jimmunol.180.5.3383. View